← Leaderboards
Kevin Kuo
Phoenicia Biosciences, Inc.
$1,301,706
Attributed
$5,206,823
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2020–22$2M$1.5M$1M$500K$0
'20
'21
'22
Funding mix
By agency
NIH$5,206,823 · 1
By mechanism
R33$5,206,823 · 1
Top collaborators
- Douglas V Faller3 shared
- Susan P Perrine3 shared
- Sylvia T Singer3 shared
Others in their field
Other Emerging Leaders on “Amino Acids”
- Alan James Bridge · European Molecular Biology Laboratory$8,787,716
- Ian R Lanza · Mayo Clinic Rochester$5,625,920
- Chitra Upadhyay · Icahn School Of Medicine At Mount Sinai$4,972,038
- Rui Kong · Emory University$4,675,382
- Ahmed Abdelfattah · Brown University$4,550,209
- Alon Herschhorn · University Of Minnesota$4,482,305
Research focus
Amino AcidsBenignBenserazideBeta ThalassemiaBilirubinCanadaCellsChronicClinical TrialsCohortDecarboxylase InhibitorDoseDrug KineticsErythrocytesErythroidEuropeFetalFetal DevelopmentFetal HemoglobinGamma GlobinGenesGeneticGlobal HealthAdult